SCHEMBL7752855

SCHEMBL7752855

O=C(O)C(=Cc1ccccc1)C(O)(O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.48
CYP2C9 P11712 2/20 0.47
CYP3A4 P08684 1/20 0.47
AKR1C1 Q04828 1/20 0.47
TP53 P04637 1/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
RECQL P46063 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MCL1 Q07820 1/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
HDAC3 O15379 1/20 0.38
TNKS O95271 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL225383 0.79 AKR1C3 (0.57) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL4731168 0.78 AKR1C3 (0.47) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL10719619 0.78 AKR1C3 (0.50) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL1805525 0.78 AKR1C3 (0.50) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL525210 0.78 AKR1C3 (0.55) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL525211 0.78 AKR1C3 (0.55) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL7146881 0.78 AKR1C3 (0.50) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL564118 0.78 AKR1C3 (0.50) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL8054477 0.78 AKR1C3 (0.50) AKR1C3CYP2C9CYP3A4AKR1C1TP53
SCHEMBL17102367 0.76 AKR1C3 (0.48) AKR1C3CYP2C9CYP3A4AKR1C1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063888-A1 NOVEL HIV INTEGRASE INHIBITORS AND HIV THERAPY BASED ON DRUG COMBINATIONS INCLUDING INTEGRASE INHIBITORS The Regents of the University of California (US) 2001-01-03 EP claimed
WO-1999048371-A1 NOVEL HIV INTEGRASE INHIBITORS AND HIV THERAPY BASED ON DRUG COMBINATIONS INCLUDING INTEGRASE INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-09-30 WO claimed